Sven Wehrwein - Proto Labs Independent Chairman of the Board
| PRLB Stock | USD 40.80 0.31 0.75% |
Chairman
Mr. Sven A. Wehrwein, CPA was appointed as Independent Chairman of the Board of the Company, with effect from May 2017 . He serves as lead director, as chair of the audit committee, and as a member of the nominating and governance committee. Mr. Wehrwein was an independent financial consultant to emerging companies since 1999. During his 35plus years in accounting and finance, he has experience as a certified public accountant, investment banker to emerging growth companies, chief financial officer and audit committee chair. Mr. Wehrwein currently serves on the board of directors of AtriCure, Inc., a medical device company, and SPS Commerce, Inc., a supplychain management software company, both of which are publicly traded companies. Mr. Wehrwein also served on the board of directors of Compellent Technologies, Inc. from 2007 until its acquisition by Dell Inc. in 2011, on the board of Vital Images, Inc. from 1997 until its acquisition by Toshiba Medical in 2011, on the board of Synovis Life Technologies, Inc. from 2004 until its acquisition by Baxter International, Inc. in 2012, on the board of directors of Image Sensing Systems, Inc. from 2006 to 2012, and on the board of Cogentix Medical, Inc. from 2006 to 2016 since 2020.
| Age | 69 |
| Tenure | 4 years |
| Address | 5540 Pioneer Creek Drive, Maple Plain, MN, United States, 55359 |
| Phone | 763 479 3680 |
| Web | https://www.protolabs.com |
Sven Wehrwein Latest Insider Activity
Tracking and analyzing the buying and selling activities of Sven Wehrwein against Proto Labs stock is an integral part of due diligence when investing in Proto Labs. Sven Wehrwein insider activity provides valuable insight into whether Proto Labs is net buyers or sellers over its current business cycle. Note, Proto Labs insiders must abide by specific rules, including filing SEC forms every time they buy or sell Proto Labs'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Sven Wehrwein over six months ago Acquisition by Sven Wehrwein of 4701 shares of Proto Labs subject to Rule 16b-3 | ||
Sven Wehrwein over six months ago Exercise or conversion by Sven Wehrwein of 3000 shares of SPS Commerce subject to Rule 16b-3 | ||
Sven Wehrwein over a year ago Acquisition by Sven Wehrwein of 1731 shares of Proto Labs subject to Rule 16b-3 | ||
Sven Wehrwein over a year ago Exercise or conversion by Sven Wehrwein of 732 shares of SPS Commerce subject to Rule 16b-3 |
Proto Labs Management Efficiency
The company has return on total asset (ROA) of 0.0242 % which means that it generated a profit of $0.0242 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0352 %, meaning that it created $0.0352 on every $100 dollars invested by stockholders. Proto Labs' management efficiency ratios could be used to measure how well Proto Labs manages its routine affairs as well as how well it operates its assets and liabilities. As of November 28, 2024, Return On Tangible Assets is expected to decline to 0.03. In addition to that, Return On Capital Employed is expected to decline to 0.04. At present, Proto Labs' Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.41, whereas Total Assets are forecasted to decline to about 487.9 M.Similar Executives
| Found 9 records | CHAIRMAN Age | ||
| Gregory Pratt | Carpenter Technology | 71 | |
| John Gottwald | Tredegar | 66 | |
| H Woltz | Insteel Industries | 64 | |
| Diane Creel | Allegheny Technologies Incorpor | 71 | |
| Robert Wetherbee | Allegheny Technologies Incorpor | 65 | |
| John McConnell | Worthington Industries | 70 | |
| I Inglis | Carpenter Technology | 69 | |
| Robert Kamphuis | Mayville Engineering Co | 62 | |
| William Gottwald | Tredegar | 72 | |
Management Performance
| Return On Equity | 0.0352 | ||||
| Return On Asset | 0.0242 |
Proto Labs Leadership Team
Elected by the shareholders, the Proto Labs' board of directors comprises two types of representatives: Proto Labs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Proto. The board's role is to monitor Proto Labs' management team and ensure that shareholders' interests are well served. Proto Labs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Proto Labs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Oleg Ryaboy, Global Officer | ||
| Brian Peters, Chief Officer | ||
| Stacy Greiner, Director | ||
| Dan Schumacher, Interim Chief Financial Officer | ||
| Rainer Gawlick, Independent Director | ||
| Bram Zwart, Head Hubs | ||
| CPA CGMA, Controller Secretary | ||
| Robert Bodor, President, Chief Executive Officer, Interim Chief Technology Officer, Director | ||
| Sujeet Chand, Independent Director | ||
| Bjoern Klaas, Vice President, General Manager and Managing Director - Europe, Middle East and Africa | ||
| Victoria Holt, CEO and President and Director | ||
| Archie Black, Independent Chairman of the Board | ||
| Daniel Schumacher, Chief Officer | ||
| Sven Wehrwein, Independent Chairman of the Board | ||
| Alex Cappy, VP Hubs | ||
| Jason Frankman, Controller Secretary | ||
| John Way, Chief Financial Officer, Executive Vice President of Development | ||
| Arthur Baker, Chief Technology Officer | ||
| Moonhie Chin, Independent Director | ||
| Michael Kenison, VP Americas | ||
| Agnes Semington, Chief Officer | ||
| Donald Krantz, Executive VP and Technology Officer | ||
| John Goodman, Independent Director | ||
| Renee Conklin, VP HR |
Proto Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Proto Labs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0352 | ||||
| Return On Asset | 0.0242 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 903.6 M | ||||
| Shares Outstanding | 24.51 M | ||||
| Shares Owned By Insiders | 0.92 % | ||||
| Shares Owned By Institutions | 91.37 % | ||||
| Number Of Shares Shorted | 711.04 K | ||||
| Price To Earning | 27.47 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Proto Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Proto Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Proto Labs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Proto Labs Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Proto Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Proto Stock refer to our How to Trade Proto Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Proto Labs. If investors know Proto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Proto Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 0.94 | Revenue Per Share 19.816 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0242 |
The market value of Proto Labs is measured differently than its book value, which is the value of Proto that is recorded on the company's balance sheet. Investors also form their own opinion of Proto Labs' value that differs from its market value or its book value, called intrinsic value, which is Proto Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Proto Labs' market value can be influenced by many factors that don't directly affect Proto Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Proto Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Proto Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Proto Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.